[Drug treatment of patients with the chronic form of atrial fibrillation in counterindications for cardioversion (a review)].
Vorob'ev
L P
LP
Kaziulin
A N
AN
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D045930:Anabolic Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002908:Chronic Disease; D004554:Electric Countershock; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008981:Molsidomine; D009200:Myocardial Contraction / Q000187:drug effects; D012008:Recurrence; D013558:Sydnones / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D002121:Calcium Channel Blockers; D002301:Cardiac Glycosides; D013558:Sydnones; D014665:Vasodilator Agents; D002216:Captopril; D008981:Molsidomine; D000638:Amiodarone
Medikamentoznoe lechenie bol'nykh s khronicheskoĭ formoĭ mertsatel'noĭ aritmii pri protivopokazaniiakh k kardioversii (obzor).